Showing results (91-100 of 99) with videos related to

Sort By:
Pageof 10
You have reached the last page of results.This site can display upto 99 results.
Cell Death & Disease|April 15, 2011
Calpain-mediated cleavage of Beclin-1 and autophagy deregulation following retinal ischemic injury in vivoR Russo, L Berliocchi, A Adornetto, et al.
Amino Acids|August 4, 2004
Transglutaminase 5 is acetylated at the N-terminal endA Rufini, F Vilbois, A Paradisi, et al.
Nature Neuroscience|June 27, 2001
CXCR4-activated astrocyte glutamate release via TNFalpha: amplification by microglia triggers neurotoxicityP Bezzi, M Domercq, L Brambilla, et al.
Journal of Neurochemistry|September 23, 2008
Modulation of pro-survival and death-associated pathways under retinal ischemia/reperfusion: effects of NMDA receptor blockadeR Russo, F Cavaliere, L Berliocchi, et al.
Frontiers in Pharmacology|December 28, 2023
Combination of anti-CGRP/CGRP-R mAbs with onabotulinumtoxin A as a novel therapeutic approach for refractory chronic migraine: a retrospective study of real-world clinical evidence and a protocol for a double-blind, randomized clinical trial to establish the efficacy and safetyM T Corasaniti, G W Lawrence, G Bagetta, et al.
Mini Reviews in Medicinal Chemistry|March 22, 2016
Rational Basis for the Use of Bergamot Essential Oil in Complementary Medicine to Treat Chronic PainL Rombolà, D Amantea, R Russo, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|June 5, 2022
Pain and agitation treatment in severe dementia patients: The need for Italian Mobilization-Observation-Behavior-Intensity-Dementia (I-MOBID2) pain scale translation, adaptation and validation with psychometric testingD Scuteri, M Contrada, T Loria, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|December 10, 2021
Is there a rational basis for cannabinoids research and development in ocular pain therapy? A systematic review of preclinical evidenceD Scuteri, L Rombolà, K Hamamura, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|October 17, 2022
2-pentadecyl-2-oxazoline prevents cognitive and social behaviour impairments in the Amyloid β-induced Alzheimer-like mice model: Bring the α2 adrenergic receptor back into playR Infantino, S Boccella, D Scuteri, et al.
Pageof 10